Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation

Psychopharmacology

Volumn 170, Issue 3, 2003, Pages 255-262

  Daskalakis, Zafiris J ^a,d   Christensen, Bruce K ^a   Chen, Robert ^b   Fitzgerald, Paul B ^c   Zipursky, Robert B ^a   Kapur, Shitij ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MONASH UNIVERSITY   (Australia)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Antipsychotics; Cortex; Inhibition; Schizophrenia; TMS

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL SILENT PERIOD; DOPAMINERGIC SYSTEM; DRUG MECHANISM; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR ACTIVITY; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NEUROTRANSMISSION; NORMAL HUMAN; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SHORT INTERVAL INTRACORTICAL INHIBITION; SIDE EFFECT; TRANSCALLOSAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL ANALOG SCALE;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CEREBRAL CORTEX; ELECTROMYOGRAPHY; FEMALE; HALF-LIFE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED;

EID: 0344082233     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1548-1     Document Type: Article

References (43)

1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders [see comments]. Trends Neurosci 12:366-375
2. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia- thalamocortical circuits: parallel substrates for motor, oculo-motor, "prefrontal" and "limbic" functions. Prog Brain Res 85:119-146
3. Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27
4. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44:88-97
5. Boroojerdi B, Topper R, Foltys H, Meincke U (1999) Transcallosal inhibition and motor conduction studies in patients with schizophrenia using transcranial magnetic stimulation. Br J Psychiatry 175:375-379
6. Cantello R, Gianelli M, Civardi C, Mutani R (1992) Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 42:1951-1959
7. Chen R, Samii A, Canos M, Wassermann EM, Hallett M (1997) Effects of phenytoin on cortical excitability in humans. Neurology 49:881-883
8. Chen R, Tam A, Butefisch C, Corwell B, Ziemann U, Rothwell JC, Cohen LG (1998) Intracortical inhibition and facilitation in different representations of the human motor cortex. J Neurophysiol 80:2870-2881
9. Chen R, Lozano AM, Ashby P (1999) Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res 128:539-542
10. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S (2002) Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry 59:347-354
11. del Rio MR, DeFelipe J (1997) Colocalization of parvalbumin and calbindin D-28 k in neurons including chandelier cells of the human temporal neocortex. J Chem Neuroanat 12:165-173
12. Di Lazzaro V, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC (1999) Direct demonstration of interhemispheric inhibition of the human motor cortex produced by transcranial magnetic stimulation. Exp Brain Res 124:520-524
13. Farnbach-Pralong D, Bradbury R, Copolov D, Dean B (1998) Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors. Eur J Pharmacol 349:R7-8
14. Ferbert A, Priori A, Rothwell JC, Day BL, Colebatch JG, Marsden CD (1992) Interhemispheric inhibition of the human motor cortex. J Physiol 453:525-546
15. Fuhr P, Agostino R, Hallett M (1991) Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 81:257-262
16. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15:285-320
17. Greenberg BD, Ziemann U, Cora-Locatelli G, Harmon A, Murphy DL, Keel JC, Wassermann EM (2000) Altered cortical excitability in obsessive-compulsive disorder. Neurology 54:142-147
18. Inghilleri M, Berardelli A, Cruccu G, Manfredi M (1993) Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol 466:521-534
19. Kaneko K, Kawai S, Fuchigami Y, Morita H, Ofuji A (1996) The effect of current direction induced by transcranial magnetic stimulation on the corticospinal excitability in human brain. Electroencephalogr Clin Neurophysiol 101:478-482
20. Kapur S, Seeman P (2001) Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 158:360-369
21. 2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 155:921-928
22. Krnjevic K (1997) Role of GABA in cerebral cortex. Can J Physiol Pharmacol 75:439-451
23. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD (1993) Cortico-cortical inhibition in human motor cortex. J Physiol (Lond) 471:501-519
24. Liepert J, Schwenkreis P, Tegenthoff M, Malin JP (1997) The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm 104:1207-1214
25. Moll GH, Heinrich H, Wischer S, Tergau F, Paulus W, Rothenberger A (1999) Motor system excitability in healthy children: developmental aspects from transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol Suppl 51:243-249
26. Nakamura H, Kitagawa H, Kawaguchi Y, Tsuji H (1997) Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 498:817-823
27. 2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology 106:433-438
28. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97-113
29. 3H]GABA in the rat prefrontal cortex. Neuroscience 43:323-329
30. Ridding MC, Inzelberg R, Rothwell JC (1995) Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 37:181-188
31. Sanger TD, Garg RR, Chen R (2001) Interactions between two different inhibitory systems in the human motor cortex. J Physiol 530:307-317
32. Smiley JF, Williams SM, Szigeti K, Goldman-Rakic PS (1992) Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J Comp Neurol 321:325-335
33. Spitzer RL, Williams JBW, Gibbon M (1995) Structured clinical interview for DSM-IV (SCID). Biometrics Research
34. Tergau F, Wanschura V, Canelo M, Wischer S, Wassermann EM, Ziemann U, Paulus W (1999) Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation. Exp Brain Res 124:447-454
35. Wu JC, Potkin SG, Ploszaj DI (1992) Clozapine improves sensory gating more than Haldol. [Abstract]. American Psychiatric Association Abstracts: 156
36. Yee CM, Nuechterlein KH, Morris SE, White PM (1998) P50 suppression in recent-onset schizophrenia: clinical correlates and risperidone effects. J Abnorm Psychol 107:691-698
37. Ziemann U RJ, Ridding MC (1996) Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol (Lond) 493:873-881
38. Ziemann U, Bruns D, Paulus W (1996a) Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 208:187-190
39. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996b) The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 109:127-135
40. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W (1996c) Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study [see comments]. Ann Neurol 40:367-378
41. Ziemann U, Paulus W, Rothenberger A (1997a) Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 154:1277-1284
42. Ziemann U, Tergau F, Bruns D, Baudewig J, Paulus W (1997b) Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 105:430-437
43. Ziemann U, Chen R, Cohen LG, Hallett M (1998) Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51:1320-1324